Cargando…

Solid serous microcystic adenoma of the pancreas

BACKGROUND: Cystic neoplasms of the pancreas are less common than solid tumors, and portend a better prognosis. They can be divided into serous and mucinous subtypes, with the former behaving less aggressively and generally considered benign. Of the serous neoplasms, serous microcystic adenoma is th...

Descripción completa

Detalles Bibliográficos
Autores principales: Stern, Jordan R, Frankel, Wendy L, Ellison, E Christopher, Bloomston, Mark
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1821026/
https://www.ncbi.nlm.nih.gov/pubmed/17338818
http://dx.doi.org/10.1186/1477-7819-5-26
_version_ 1782132670251139072
author Stern, Jordan R
Frankel, Wendy L
Ellison, E Christopher
Bloomston, Mark
author_facet Stern, Jordan R
Frankel, Wendy L
Ellison, E Christopher
Bloomston, Mark
author_sort Stern, Jordan R
collection PubMed
description BACKGROUND: Cystic neoplasms of the pancreas are less common than solid tumors, and portend a better prognosis. They can be divided into serous and mucinous subtypes, with the former behaving less aggressively and generally considered benign. Of the serous neoplasms, serous microcystic adenoma is the most common. An extremely rare solid variant of serous microcystic adenoma lacking secretory capability has been described. Herein, we present the fourth described case of this solid variant and review the literature. CASE PRESENTATION: We present a case of a 62 year-old man with a history of abdominal pain, who on CT scan was found to have a solid mass at the junction of the head and body of the pancreas. The patient was offered resection for diagnosis and treatment, and subsequently underwent distal pancreatectomy and splenectomy. Based on gross pathology, histology and immunohistochemistry, the mass was determined to be a solid serous microcystic adenoma. CONCLUSION: Solid serous microcystic adenoma shows similar histologic and immunohistologic features to its classic cystic counterpart, but lacks any secretory functionality. It appears to behave in a benign manner, and as such, surgical resection is curative for patients with this tumor. Furthermore, until more cases of solid SMA are identified to further elucidate its natural history and improve the reliability of preoperative diagnosis, surgical resection of this solid pancreatic tumor should be considered standard therapy in order to exclude malignancy.
format Text
id pubmed-1821026
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18210262007-03-14 Solid serous microcystic adenoma of the pancreas Stern, Jordan R Frankel, Wendy L Ellison, E Christopher Bloomston, Mark World J Surg Oncol Review BACKGROUND: Cystic neoplasms of the pancreas are less common than solid tumors, and portend a better prognosis. They can be divided into serous and mucinous subtypes, with the former behaving less aggressively and generally considered benign. Of the serous neoplasms, serous microcystic adenoma is the most common. An extremely rare solid variant of serous microcystic adenoma lacking secretory capability has been described. Herein, we present the fourth described case of this solid variant and review the literature. CASE PRESENTATION: We present a case of a 62 year-old man with a history of abdominal pain, who on CT scan was found to have a solid mass at the junction of the head and body of the pancreas. The patient was offered resection for diagnosis and treatment, and subsequently underwent distal pancreatectomy and splenectomy. Based on gross pathology, histology and immunohistochemistry, the mass was determined to be a solid serous microcystic adenoma. CONCLUSION: Solid serous microcystic adenoma shows similar histologic and immunohistologic features to its classic cystic counterpart, but lacks any secretory functionality. It appears to behave in a benign manner, and as such, surgical resection is curative for patients with this tumor. Furthermore, until more cases of solid SMA are identified to further elucidate its natural history and improve the reliability of preoperative diagnosis, surgical resection of this solid pancreatic tumor should be considered standard therapy in order to exclude malignancy. BioMed Central 2007-03-05 /pmc/articles/PMC1821026/ /pubmed/17338818 http://dx.doi.org/10.1186/1477-7819-5-26 Text en Copyright © 2007 Stern et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Stern, Jordan R
Frankel, Wendy L
Ellison, E Christopher
Bloomston, Mark
Solid serous microcystic adenoma of the pancreas
title Solid serous microcystic adenoma of the pancreas
title_full Solid serous microcystic adenoma of the pancreas
title_fullStr Solid serous microcystic adenoma of the pancreas
title_full_unstemmed Solid serous microcystic adenoma of the pancreas
title_short Solid serous microcystic adenoma of the pancreas
title_sort solid serous microcystic adenoma of the pancreas
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1821026/
https://www.ncbi.nlm.nih.gov/pubmed/17338818
http://dx.doi.org/10.1186/1477-7819-5-26
work_keys_str_mv AT sternjordanr solidserousmicrocysticadenomaofthepancreas
AT frankelwendyl solidserousmicrocysticadenomaofthepancreas
AT ellisonechristopher solidserousmicrocysticadenomaofthepancreas
AT bloomstonmark solidserousmicrocysticadenomaofthepancreas